Several Israeli companies landed on The New York Times Dealbook’s list of the best business deals of 2011.

Dealbook praised The China National Chemical Corporation and partner Koor Industries of Israel for buying 60 percent of Makhteshim, an Israeli agricultural chemical company.

“The deal, valued at $2.4 billion, was one of the largest outbound investments by China ever, and showed that the country was on the prowl internationally for crucial suppliers,” Dealbook wrote.

The website also lauded Teva Pharmaceutical Industries’ acquisition of Cephalon for $6.8 billion, saying the Israeli company “showed the value of opportunistic and quick action” when making a deal.

Fundtech received mention for its aborted stock-for-stock merger with S1. Both companies were then acquired by different companies—Fundtech by GTCR and S1 by ACI—that submitted offers after hearing about the proposed merger.

Dealbook said that the deal “showed the rare ability of a bidder to top a stock-for-stock deal and not only disrupt it but end up on the winning end.”